Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8705 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8705 |
High Similarity |
NPD5124 |
Phase 1 |
0.8356 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD4140 |
Approved |
0.8235 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8231 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8227 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8227 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8138 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8071 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.8041 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7972 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7971 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7949 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7914 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7895 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7867 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD4749 |
Approved |
0.781 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7785 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7785 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7764 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7754 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7742 |
Intermediate Similarity |
NPD1653 |
Approved |
0.774 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7736 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7724 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7722 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7718 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7718 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7707 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7698 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7692 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7676 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7658 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7619 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7566 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7562 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7547 |
Intermediate Similarity |
NPD37 |
Approved |
0.7533 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4965 |
Approved |
0.75 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3267 |
Approved |
0.75 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5535 |
Approved |
0.75 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7484 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7453 |
Intermediate Similarity |
NPD5402 |
Approved |
0.745 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7417 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7417 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7412 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7351 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7347 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7325 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7325 |
Intermediate Similarity |
NPD2534 |
Approved |
0.732 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7313 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7292 |
Intermediate Similarity |
NPD1608 |
Approved |
0.729 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7251 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7233 |
Intermediate Similarity |
NPD920 |
Approved |
0.723 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7171 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7162 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7161 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7123 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7107 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD17 |
Approved |
0.708 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7075 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7073 |
Intermediate Similarity |
NPD2801 |
Approved |
0.707 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7052 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7035 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7029 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7027 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7018 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7011
|
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |